ScholarIQanswers from OpenAlex & ORCID
Samuel S. Blumenthal
ResearcherPublications, citations & collaboration network
Samuel S. Blumenthal is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Samuel S. Blumenthal have?
ScholarIQindexed works
Samuel S. Blumenthal has 50 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Samuel S. Blumenthal have?
ScholarIQcitation count
Samuel S. Blumenthal has 4,126 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Samuel S. Blumenthal?
ScholarIQh-index
Samuel S. Blumenthal has an h-index of 27 in OpenAlex.
What is the i10-index of Samuel S. Blumenthal?
ScholarIQi10-index
Samuel S. Blumenthal has an i10-index of 38 in OpenAlex.
What is the OpenAlex record for Samuel S. Blumenthal?
ScholarIQopenalex
The OpenAlex for Samuel S. Blumenthal is on the source record.
What are the most-cited papers on Samuel S. Blumenthal?
ScholarIQmost cited works
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, George L. Bakris, Ricardo Correa-Rotter, Fan Fan Hou, Dalane W. Kitzman, Donald Kohan, Hirofumi Makino, John J.V. McMurray, Joel Z. Melnick, Michael G. Miller, Pablo E. Pérgola, Vlado Perkovic, Sheldon W. Tobe, Tingting Yi, Melissa Wigderson, Dick de Zeeuw, Alicia Elbert, Augusto Vallejos, Andres Alvarisqueta, Laura Maffei, Luis I. Juncos, Javier de Arteaga, Gustavo Greloni, Eduardo Farias, A Zucchini, Daniel Vogel, Ana María Cusumano, Juan Carlos Santos, Margaret B. Fraenkel, Martin Gallagher, Timothy M. E. Davis, Shamasunder Acharya, Duncan Cooke, Michael Suranyi, Simon D. Roger, Nigel D. Toussaint, Carol A. Pollock, Doris Chan, Stephen Stranks, Richard J. MacIsaac, Zoltán Endre, Alice Schmidt, Rudolf Prager, Gert Mayer, Xavier Warling, Michel Jadoul, Jean Hougardy, Chris Vercammen, Bruno Van Vlem, Pieter Gillard, Adriana Costa e Forti, João Borges, Luis Santos Canani, Freddy G. Eliaschewitz, Silmara Leite, Fadlo Fraige Filho, Raphael Paschoalin, José A. Moura-Neto, Luciane Mônica Deboni, Irene de Lourdes Noronha, Cíntia Cercato, Carlos Alberto Prompt, Maria Teresa Zanella, Nelson Rassi, Domingos O. d’Avila, Rosângela Milagres, João Soares Felício, Roberto Pecoits‐Filho, Miguel C. Riella, João Eduardo Nunes Salles, Elizete Keitel, Sérgio Antônio Draibe, Celso Amodeo, J. T. Youmbissi, Louise Roy, Serge Cournoyer, Shivinder Jolly, Vincent Pichette, Gihad Nesrallah, Harpreet S. Bajaj, Hasnain Khandwala, Ronnie Aronson, Richard Goluch, Paul Kwong Hang Tam, Christian Rabbat, Sheldon W. Tobe, G. HOWARD BAILEY, S. P. Chow, A Castillo, Alfredo Danin Vargas, Fernando González, Rodrigo Muñoz, Vicente Gutiérrez, Gonzalo Godoy, Hongwen Zhao, Zhangsuo Liu, Ming‐Hui Zhao, Xiaohui Guo
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour, Brad H. Rovin, Richard Lafayette, Nabeel Aslam, Jonathan Ashley Jefferson, Patrick E. Gipson, Dana V. Rizk, John R. Sedor, James F. Simon, Ellen T. McCarthy, Paul Brenchley, Sanjeev Sethi, Carmen Ávila-Casado, Heather Beanlands, John C. Lieske, David Philibert, Tingting Li, Leslie F. Thomas, Dolly F. Green, Luis A. Juncos, Lada Beara‐Lasić, Samuel S. Blumenthal, Amy N. Sussman, Stephen B. Erickson, Michelle Hladunewich, Pietro A. Canetta, Lee A. Hebert, Nelson Leung, Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran
Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial
Marc A. Pohl, Samuel S. Blumenthal, D Cordonnier, Fernando de Álvaro, Giacomo Deferrari, Gilbert M. Eisner, Enric Esmatjes, Richard E. Gilbert, Lawrence G. Hunsicker, José B. Lopes de Faria, Ruggero Mangili, Jack Moore, Efrain Reisin, Eberhard Ritz, Guntram Schernthaner, Samuel Spitalewitz, H Tindall, Roger A. Rodby, Edmund J. Lewis
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
James R. Voelker, Paul H. Berg, Matthew J. Sheetz, Kevin L. Duffin, Tong Shen, Brian A. Moser, Tom Greene, Samuel S. Blumenthal, Ivan Rychlík, Yoram Yagil, Philippe Zaoui, Julia B. Lewis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of AST-120 (Kremezin) in Patients With Moderate to Severe CKD
Gerald Schulman, Rajiv Agarwal, Muralidhar Acharya, Tomás Berl, Samuel S. Blumenthal, Nelson Kopyt